Tag: CX 2025
CIARTIC Move offers procedural control “far beyond” current solutions in endovascular...
At the 2025 Charing Cross (CX) Symposium (23-25 April, London, UK), Michele Antonello (Padua, Italy) and Nikolaos Tsilimparis (Munich, Germany) sat down to discuss...
New robotic C-arm goes “far and beyond” current technologies in endovascular...
This advertorial is sponsored by Siemens Healthineers.
Speaking to Michele Antonello (University of Padua, Padua, Italy) at the 2025 Charing Cross (CX) Symposium (23–25 April,...
Patient selection and reproducibility are essential in carotid revascularisation—regardless of chosen...
Following a lively, three-pronged debate on the ‘gold standard’ in carotid revascularisation at this year’s Charing Cross (CX) Symposium (23–25 April, London, UK), a...
FLEXing across the pond: real-world insights from both sides of the...
In a candid, cross-continental exchange, vascular surgeons Robert Shahverdyan (Hamburg, Germany) and Ari Kramer (Spartanburg, USA) share their real-world experiences using the FLEX Vessel...
Pathways and multidisciplinary teams “critical” in shaping future venous care
At this year’s Charing Cross (CX) Symposium (23–25 April, London, UK), Manj Gohel (Cambridge University Hospitals, Cambridge, UK) spoke with Stephen Black (Guy’s and...
Robotic vascular surgery: Could robotics be the key to the specialty’s...
Can the world of vascular surgery return to the core therapeutic components of open surgery, unite them with the skillset brought by the endovascular...
Nectero Medical secures category III CPT codes for investigational therapy to...
Nectero Medical recently announced that the American Medical Association’s CPT editorial panel has approved two category III CPT codes applicable to the Nectero endovascular...
Vascular News North America 106 – June 2025
In this issue:
CX 2025: Cost-effectiveness outcomes defy expectations in latest BEST-CLI data drop
Reality check: Study brings “significant” gap between randomised and real-world...
Vascular News Europe 106 – June 2025
In this issue:
CX 2025: Cost-effectiveness outcomes defy expectations in latest BEST-CLI data drop
Reality check: Study brings “significant” gap between randomised and real-world...
CX 2025: Cost-effectiveness outcomes defy expectations in latest BEST-CLI data drop
A comment from Andrew Holden (Auckland City Hospital, Auckland, New Zealand) conveyed surprise at new cost-effectiveness data from the BEST-CLI trial that were shared...
CX 2025: Largest analysis of atherectomy data points towards lower target-lesion...
In the largest systematic review and meta-analysis of atherectomy data to date, Thomas Zeller (Bad Krozingen, Germany) reported that the technique is effective in...
CX 2025: Carotid endarterectomy maintains its golden hue in ‘great debate’
The established ‘gold standard’ approach to carotid revascularisation remained enshrined as the go-to operation as far as the CX audience gathered in Theatre 3...
CX 2025: Managing blood pressure with medical therapy may play a...
Results from the Central blood pressure and variability evaluation in abdominal aortic aneurysm (AAA), or CAVE-ON, study, which sought to measure the impact of...
CX 2025: EVAR founding fathers invoke revolutionary past to predict path...
The next spring forward in aortic stent grafting will be rooted in a greater understanding of the biomechanical forces acting upon devices alongside continued...
CX 2025: Sirolimus implant fails to meet fistula maturation endpoint in...
Results of the ACCESS 2 study, evaluating arteriovenous fistula (AVF) outcomes following use of the Sirogen (Vascular Therapies) sirolimus-eluting collagen implant, have shown that...
CX 2025: Bioresorbable scaffold technology has “potential to be a new...
In Wednesday's peripheral arterial programme, which hosted several podium-first presentations, lower limb drug-eluting technologies took centre stage—signalling a potential shift in the treatment paradigm...
Founding fathers of EVAR mark 40 years of aortic stent graft...
The 40-year history of endovascular aneurysm repair (EVAR) of the aorta wends a circuitous route, from behind the Iron Curtain in Soviet Ukraine, to...
New data, case discussion and debates to address critical challenges in...
New data and hot topic debates form the centrepiece of today’s (Wednesday’s) vascular access and renal interventions sessions at CX 2025, running throughout the...
New “The Swollen Leg” competition to raise public awareness of DVT...
The Rouleaux Club—the UK’s national vascular trainee society—in association with the CX Symposium 2025 and BIBA Medical, has announced a new competition intended to...
CX 2025 meets “critical” vascular challenges with plethora of new data
More than 50 podium-first presentations headline the 47th Charing Cross (CX) International Symposium—opening today (Wednesday 23 April) at the ExCeL London—with the aim of...
No longer a ‘one-trick shop’: Venous becomes core pillar of CX...
Charting the development of the Charing Cross (CX) venous and lymphatic programme from a sidebar event to becoming an “integral part” of the meeting’s...
Awaited first-release data and debates set to address critical challenges in...
“These crucial results will help to shape next steps in research, including ongoing randomised controlled trials comparing bioresorbable scaffolds to angioplasty, and eventually, to...
Challenges of 21st century aortic education, innovation and evidence get top...
Critical challenges in open and endovascular treatment of aortic disease will be brought into focus when world leaders in cardiac, aortic, and vascular therapies...
